This role will ensure high-quality, consistent, and compliant data, managing a team responsible for developing, validating, and implementing immunological ligand-binding methods that support clinical endpoints across vaccine trials from Phase I through Phase IV. The Global Clinical Immunology (GCI) organization, part of Late Stage Global Immunology within Vaccines R&D, specializes in developing, validating, and deploying regulated bioanalytical assays to assess immune responses to vaccines throughout their lifecycle.